Science Explorer Back to mapMap
Discussion
Researcher · Tetraphase Pharmaceuticals (United States) · United States

Sergey Izmailyan

Sergey Izmailyan publishes mostly in Pharmacology, Epidemiology and Molecular Medicine, on topics such as Antibiotics Pharmacokinetics and Efficacy, Antibiotic Resistance in Bacteria and Antibiotic Use and Resistance.

ORCID 0000-0001-9589-7399 OpenAlex
World rank
#5,067,717
of 7,710,434 ranked researchers
Rank in United States
#1,310,393
of 1,627,098
Works
15
Citations
207
Citations per work
13.8
h-index
7
i10-index 6Top 79% in Pharmacology (Medicine)
Sergey Izmailyan

What does Sergey Izmailyan research?

Sergey Izmailyan's work is mostly in Medicine (36%), Biochemistry, Genetics and Molecular Biology (16%), Immunology and Microbiology (7%).

Everything else: 6 works · 40.9% of their workHealth Sciences: 5 works · 36.4% of their workMedicine: 5 works · 36.4% of their workPharmacology: 3 works · 18.2% of their workEpidemiology: 2 works · 11.4% of their workInfectious Diseases: 1 works · 6.8% of their workLife Sciences: 3 works · 22.7% of their workBiochemistry, Genetics and Molecular Biology: 2 works · 15.9% of their workMolecular Medicine: 1 works · 9.1% of their workMolecular Biology: 1 works · 6.8% of their workImmunology and Microbiology: 1 works · 6.8% of their workApplied Microbiology and Biotechnology: 1 works · 6.8% of their workTHEIR WORKSergey Izmailyan15works
Life Sciences23%Health Sciences36%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else640.9%
    1. Medicine536.4%
    1. Biochemistry, Genetics and Molecular Biology215.9%
    2. Immunology and Microbiology16.8%
  1. 1Pharmacology18% of their works
  2. 2Epidemiology11% of their works
  3. 3Molecular Medicine9% of their works
  4. 4Infectious Diseases7% of their works
  5. 5Applied Microbiology and Biotechnology7% of their works
  6. 6Molecular Biology7% of their works

Research topics

Which keywords describe Sergey Izmailyan's research?

The keywords of their largest research topics: Antibiotic Pharmacokinetics, Antibiotic Resistance, Critically Ill Patients, Drug Resistance, Epidemiology, Management, ESKAPE Pathogens and Multidrug-Resistant Bacteria.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Antibiotic Pharmacokinetics71 topic
  2. Antibiotic Resistance72 topics
  3. Critically Ill Patients71 topic
  4. Drug Resistance62 topics
  5. Epidemiology52 topics
  6. Management52 topics
  7. ESKAPE Pathogens41 topic
  8. Multidrug-Resistant Bacteria41 topic
  9. Antimicrobial Stewardship31 topic
  10. Antiretroviral Therapy31 topic
  11. Appendicitis31 topic
  12. Diagnosis31 topic
  13. Global Health31 topic
  14. HIV Infection31 topic
  15. DNA21 topic
  16. Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry21 topic
  17. Microorganism Identification21 topic
  18. Sepsis21 topic
  19. Septic Shock21 topic
  20. Topoisomerases21 topic

Where does Sergey Izmailyan work?

Sergey Izmailyan's main affiliation in the publication record is Tetraphase Pharmaceuticals (United States), United States.

How many publications and citations does Sergey Izmailyan have?

OpenAlex counts 15 works and 207 citations for Sergey Izmailyan, an h-index of 7, ranking #5,067,717 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Sergey Izmailyan. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.